TADV was associated with significantly beder limb salvage, survival, and amputation-free survival at 1 year compared to untreated no-option CLTI patients, confirming the global generalizability and consistency of the procedure. These outcome improvements with TADV can be achieved at an incremental cost that renders it a cost-effective, high value intervention in a model-based analysis.
